Literature DB >> 24773203

Modulation of fatty acid and bile acid metabolism by peroxisome proliferator-activated receptor α protects against alcoholic liver disease.

Heng-Hong Li1, John B Tyburski, Yi-Wen Wang, Steve Strawn, Bo-Hyun Moon, Bhaskar V S Kallakury, Frank J Gonzalez, Albert J Fornace.   

Abstract

BACKGROUND: Chronic alcohol intake affects liver function and causes hepatic pathological changes. It has been shown that peroxisome proliferator-activated receptor α (PPARα)-null mice developed more pronounced hepatic changes than wild-type (WT) mice after chronic exposure to a diet containing 4% alcohol. The remarkable similarity between the histopathology of alcoholic liver disease (ALD) in Ppara-null model and in humans, and the fact that PPARα expression and activity in human liver are less than one-tenth of those in WT mouse liver make Ppara-null a good system to investigate ALD.
METHODS: In this study, the Ppara-null model was used to elucidate the dynamic regulation of PPARα activity during chronic alcohol intake. Hepatic transcriptomic and metabolomic analyses were used to examine alterations of gene expression and metabolites associated with pathological changes. The changes triggered by alcohol consumption on gene expression and metabolites in Ppara-null mice were compared with those in WT mice.
RESULTS: The results showed that in the presence of PPARα, 3 major metabolic pathways in mitochondria, namely the fatty acid β-oxidation, the tricarboxylic acid cycle, and the electron transfer chain, were induced in response to a 2-month alcohol feeding, while these responses were greatly reduced in the absence of PPARα. In line with the transcriptional modulations of these metabolic pathways, a progressive accumulation of triglycerides, a robust increase in hepatic cholic acid and its derivatives, and a strong induction of fibrogenesis genes were observed exclusively in alcohol-fed Ppara-null mice.
CONCLUSIONS: These observations indicate that PPARα plays a protective role to enhance mitochondrial function in response to chronic alcohol consumption by adaptive transcriptional activation and suggest that activation of this nuclear receptor may be of therapeutic value in the treatment for ALD.
Copyright © 2014 by the Research Society on Alcoholism.

Entities:  

Keywords:  Fibrogenesis; Metabolic Pathways; Metabolomics; Ppara-Null Mice; Transcriptomics

Mesh:

Substances:

Year:  2014        PMID: 24773203      PMCID: PMC4047177          DOI: 10.1111/acer.12424

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  40 in total

1.  Expression of hepatocyte growth factor, transforming growth factor alpha, and transforming growth factor beta 1 messenger RNA in various human liver diseases and correlation with hepatocyte proliferation.

Authors:  M Masuhara; M Yasunaga; K Tanigawa; F Tamura; S Yamashita; I Sakaida; K Okita
Journal:  Hepatology       Date:  1996-08       Impact factor: 17.425

2.  Bile salt-induced apoptosis involves NADPH oxidase isoform activation.

Authors:  Roland Reinehr; Stephan Becker; Verena Keitel; Andrea Eberle; Susanne Grether-Beck; Dieter Häussinger
Journal:  Gastroenterology       Date:  2005-12       Impact factor: 22.682

Review 3.  Anti-TGF-beta strategies for the treatment of chronic liver disease.

Authors:  Katja Breitkopf; Stephan Haas; Eliza Wiercinska; Manfred V Singer; Steven Dooley
Journal:  Alcohol Clin Exp Res       Date:  2005-11       Impact factor: 3.455

4.  Bile acids modulate the interferon signalling pathway.

Authors:  P Podevin; O Rosmorduc; F Conti; Y Calmus; P J Meier; R Poupon
Journal:  Hepatology       Date:  1999-06       Impact factor: 17.425

5.  Peroxisome proliferator activated receptor-alpha expression in human liver.

Authors:  C N Palmer; M H Hsu; K J Griffin; J L Raucy; E F Johnson
Journal:  Mol Pharmacol       Date:  1998-01       Impact factor: 4.436

6.  Fibrates suppress bile acid synthesis via peroxisome proliferator-activated receptor-alpha-mediated downregulation of cholesterol 7alpha-hydroxylase and sterol 27-hydroxylase expression.

Authors:  S M Post; H Duez; P P Gervois; B Staels; F Kuipers; H M Princen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-11       Impact factor: 8.311

Review 7.  PPAR control: it's SIRTainly as easy as PGC.

Authors:  Mary C Sugden; Paul W Caton; Mark J Holness
Journal:  J Endocrinol       Date:  2009-09-21       Impact factor: 4.286

8.  Regulation of peroxisome proliferator activated receptor alpha-mediated pathways in alcohol fed cytochrome P450 2E1 deficient mice.

Authors:  Y -J.Y. Wan; Y Cai; J Li; Q -X. Yuan; B French; F J. Gonzalez; S French
Journal:  Hepatol Res       Date:  2001-02       Impact factor: 4.288

9.  A probable defect in the beta-oxidation of lipids in rats fed alcohol for 6 months.

Authors:  J L Rabinowitz; J Staeffen; C L Hall; J G Brand
Journal:  Alcohol       Date:  1991 Jul-Aug       Impact factor: 2.405

10.  Hepatocyte proliferation as an indicator of outcome in acute alcoholic hepatitis.

Authors:  J W Fang; G L Bird; T Nakamura; G L Davis; J Y Lau
Journal:  Lancet       Date:  1994-04-02       Impact factor: 79.321

View more
  25 in total

Review 1.  Targeting Nrf-2 is a promising intervention approach for the prevention of ethanol-induced liver disease.

Authors:  Ning Zhao; Fang-Fang Guo; Ke-Qin Xie; Tao Zeng
Journal:  Cell Mol Life Sci       Date:  2018-06-11       Impact factor: 9.261

2.  A mouse model of alcoholic liver fibrosis-associated acute kidney injury identifies key molecular pathways.

Authors:  Shinji Furuya; Grace A Chappell; Yasuhiro Iwata; Takeki Uehara; Yuki Kato; Hiroshi Kono; Ramon Bataller; Ivan Rusyn
Journal:  Toxicol Appl Pharmacol       Date:  2016-09-15       Impact factor: 4.219

Review 3.  Endocrine Adiponectin-FGF15/19 Axis in Ethanol-Induced Inflammation and Alcoholic Liver Injury.

Authors:  Min You; Zhou Zhou; Michael Daniels; Alvin Jogasuria
Journal:  Gene Expr       Date:  2017-11-02

4.  A Lipidomic and Metabolomic Serum Signature from Nonhuman Primates Exposed to Ionizing Radiation.

Authors:  Evan L Pannkuk; Evagelia C Laiakis; Tytus D Mak; Giuseppe Astarita; Simon Authier; Karen Wong; Albert J Fornace
Journal:  Metabolomics       Date:  2016-03-15       Impact factor: 4.290

Review 5.  Pathogenesis of Alcohol-Associated Fatty Liver: Lessons From Transgenic Mice.

Authors:  Afroza Ferdouse; Robin D Clugston
Journal:  Front Physiol       Date:  2022-07-05       Impact factor: 4.755

Review 6.  Mechanisms of intrahepatic triglyceride accumulation.

Authors:  Claudia Ress; Susanne Kaser
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

Review 7.  Pathogenesis of Alcoholic Liver Disease.

Authors:  Winston Dunn; Vijay H Shah
Journal:  Clin Liver Dis       Date:  2016-03-28       Impact factor: 6.126

8.  Ionizing Radiation Impairs T Cell Activation by Affecting Metabolic Reprogramming.

Authors:  Heng-Hong Li; Yi-Wen Wang; Renxiang Chen; Bin Zhou; Jonathan D Ashwell; Albert J Fornace
Journal:  Int J Biol Sci       Date:  2015-05-15       Impact factor: 6.580

9.  Effect of liver histopathology on islet cell engraftment in the model mimicking autologous islet cell transplantation.

Authors:  Chirag S Desai; Khalid M Khan; Xiaobo Ma; Henghong Li; Juan Wang; Lijuan Fan; Guoling Chen; Jill P Smith; Wanxing Cui
Journal:  Islets       Date:  2017-09-13       Impact factor: 2.694

10.  Danshen protects against early-stage alcoholic liver disease in mice via inducing PPARα activation and subsequent 4-HNE degradation.

Authors:  Lei Ding; Like Wo; Zhongyan Du; Lihua Tang; Zhenyuan Song; Xiaobing Dou
Journal:  PLoS One       Date:  2017-10-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.